Paul Inman > Gowling WLG > Birmingham, England > Lawyer Profile

Gowling WLG
TWO SNOWHILL
BIRMINGHAM
B4 6WR
England
Paul Inman photo

Work Department

IP team.

Position

Partner in Wragge & Co LLP’s intellectual property team. Specialising in: patent litigation (national and multijurisdictional) particularly in the life sciences sector (example clients: Kennedy Institute of Rheumatology Research; GlaxoSmithKline; H Lundbeck A/S); UK and community design litigation (example clients: G-Star International BV). Principal important cases: Generics (UK) Limited & ors v H Lundbeck A/S [2009] UKHL 12 (for H Lundbeck); Conor Medsystems Inc v Angiotech [2007] EWCA Civ 5 (for Conor Medsystems Inc); Synthon BV v Smithkline Beecham Plc [2005] UKHL 59 (for Smithkline Beecham plc).

Career

Trained Simmons & Simmons, qualified 1995; solicitor, intellectual property team 1995-2008; Howrey LLP partner, intellectual property group, 2008-10; Wragge & Co, partner, intellectual property team (2010 to present); Wragge Lawrence Graham & Co, partner, 2014.

Education

Wellington College, Crowthorne, Berks; Durham University (1989 Molecular Biology and Biochemistry Combined BSc Hons); College of Law, London (1992 Common Professional Examination; 1993 Law Society Finals); Bristol University (1996 Diploma in Intellectual Property and Practice); Higher Courts (Civil Proceedings) Qualification (2004).

Leisure

Skiing, swimming, cycling, four children.

Lawyer Rankings

London > TMT (technology, media and telecoms) > Intellectual property: patents (contentious and non-contentious)

The patent practice at Gowling WLG, led by Kate Swaine, is considered ‘a leading IP practice’ by clients, with ‘many bright minds and creative thinkers’. Areas of strength for the team stem from the patent litigation practice, covering the life sciences, manufacturing, engineering and technology sectors, as well as SEP and FRAND strategy and litigation. Clients from the telecoms, hi-tech, and food and beverage industries also trust the team to manage their patent portfolios in a non-contentious capacity. Alexandra Brodie is notable for her SEP/FRAND litigation expertise for telecoms and technology clients, while Paul Inman is a key name in the team for high-profile pharmaceuticals patent infringement and revocation expertise. Luke Kempton and Patrick Duxbury are go-to members of the team for IP transactional work. Also of note is the medical technology team, which fields the ‘excellent’ Jon Ball and ‘superb’ Huw Evans. Life sciences specialist Jenny Davies was recently promoted to partner, while patent litigator and fluent Japanese speaker Seiko Hakada joined the team from Norton Rose Fulbright.